These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28033601)

  • 1. [Iron therapy in chronic kidney disease].
    Graczyk M; Kohmann A
    Wiad Lek; 2016; 69(5):749-752. PubMed ID: 28033601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-intravenous approaches to iron therapy in chronic kidney disease: will it improve the benefit-to-risk ratio?
    Besarab A
    Nephrol News Issues; 2014 Feb; 28(2):12, 14-5. PubMed ID: 24649747
    [No Abstract]   [Full Text] [Related]  

  • 3. Iron management in nondialysis-dependent CKD.
    Fishbane S
    Am J Kidney Dis; 2007 Jun; 49(6):736-43. PubMed ID: 17533016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of intravenous iron supplementation in chronic kidney disease: an update.
    Macdougall IC; Geisser P
    Iran J Kidney Dis; 2013 Jan; 7(1):9-22. PubMed ID: 23314137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice].
    Rottembourg J; Rostoker G
    Nephrol Ther; 2015 Dec; 11(7):531-42. PubMed ID: 26498106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron Treatment Strategies in Nondialysis CKD.
    Macdougall IC
    Semin Nephrol; 2016 Mar; 36(2):99-104. PubMed ID: 27236130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial.
    Pisani A; Riccio E; Sabbatini M; Andreucci M; Del Rio A; Visciano B
    Nephrol Dial Transplant; 2015 Apr; 30(4):645-52. PubMed ID: 25395392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.
    Qunibi WY
    Arzneimittelforschung; 2010; 60(6a):399-412. PubMed ID: 20648931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Deficiency Anemia in Chronic Kidney Disease.
    Gafter-Gvili A; Schechter A; Rozen-Zvi B
    Acta Haematol; 2019; 142(1):44-50. PubMed ID: 30970355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heme iron polypeptide for the management of anaemia of chronic kidney disease.
    Dull RB; Davis E
    J Clin Pharm Ther; 2015 Aug; 40(4):386-90. PubMed ID: 25953602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anemia and iron deficiency - treatment options in chronic kidney disease and in chronic heart failure].
    Emrich IE; Böhm M; Heine GH
    Dtsch Med Wochenschr; 2020 Dec; 145(24):1775-1780. PubMed ID: 33254253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous iron and chronic kidney disease.
    Auerbach M
    Am J Hematol; 2014 Nov; 89(11):1083. PubMed ID: 25219516
    [No Abstract]   [Full Text] [Related]  

  • 14. Iron deficiency anemia in chronic kidney disease: Uncertainties and cautions.
    Agarwal R
    Hemodial Int; 2017 Jun; 21 Suppl 1():S78-S82. PubMed ID: 28403561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budget Impact Analysis of Oral Fisiogen Ferro Forte
    Darbà J; Ascanio M
    Clin Drug Investig; 2018 Sep; 38(9):801-811. PubMed ID: 29934762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liposomial iron: a new proposal for the treatment of anaemia in chronic kidney disease].
    Visciano B; Nazzaro P; Tarantino G; Taddei A; Del Rio A; Mozzillo GR; Riccio E; Capuano I; Pisani A
    G Ital Nefrol; 2013; 30(5):. PubMed ID: 24402627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis.
    Riccio E; Sabbatini M; Capuano I; Pellegrino AM; Petruzzelli LA; Pisani A
    BMC Nephrol; 2020 Feb; 21(1):57. PubMed ID: 32087684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal iron in moderate chronic kidney disease.
    Montagud-Marrahi E; Arrizabalaga P; Abellana R; Poch E
    Nefrologia (Engl Ed); 2020; 40(4):446-452. PubMed ID: 31892487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron therapy in chronic kidney disease: Recent changes, benefits and risks.
    Ribeiro S; Belo L; Reis F; Santos-Silva A
    Blood Rev; 2016 Jan; 30(1):65-72. PubMed ID: 26342303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues related to iron replacement in chronic kidney disease.
    Agarwal R; Warnock D
    Semin Nephrol; 2002 Nov; 22(6):479-87. PubMed ID: 12430092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.